The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut
Open accessAbstract
BACKGROUND: Normally, humans are protected against infections by their anaerobic intestinal microorganisms providing colonization resistance. In immunocompromised patients, the endogenous intestinal gram-positive and gram-negative pathogens often cause infectious complications. Therefore, we analyzed the effect of chemotherapy treatment and antimicrobial prophylaxis on intestinal bacterial populations (microbiota) among pediatric patients with acute myeloid leukemia who are prone to intestinal mucositis and infections. METHODS: During 36 chemotherapy cycles, fecal samples were collected from pediatric patients with acute myeloid leukemia. Fecal bacterial populations were analyzed by polymerase chain reaction denaturing gradient gel electrophoresis fingerprinting. Fluorescent in situ hybridization analysis with specific bacterial oligonucleotide probes was used to quantify the fecal bacteria. RESULTS: During chemotherapy treatment, the total number of bacteria in fecal samples was 10(9) per gram of dry weight feces, which was 100-fold lower than than in healthy control samples. Fluorescent in situ hybridization analysis showed that this decrease was the result of an up to 10,000-fold decrease in anaerobic bacteria, partly compensated for by a 100-fold increase in potentially pathogenic enterococci. Additional experiments showed that both prophylactic and therapeutic use of antibiotics could not sufficiently explain the tremendous changes in intestinal microbial composition. In vitro tests showed a direct bacteriostatic effect of chemotherapeutics. CONCLUSIONS: Patients with acute myeloid leukemia treated with chemotherapy and prophylactic antibiotics are unable to maintain colonization resistance because of a decrease in anaerobic bacteria and an increase in potentially pathogenic aerobic enterococci. We hypothesize that this disturbance in the balance between anaerobic and aerobic bacteria will further increase the risk of gram-positive aerobic infections among immunocompromised patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Amann, R. I., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,021
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
BODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
Zoetendal, E. G., Akkermans, A. D. L., & De Vos, W. M. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.3854-3859.1998 · Cited by 1,360
The microbiology of butyrate formation in the human colon
Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11467.x · Cited by 1,320
Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.
Cj, S., Neto, E. D., & Aj, S. (1994) · PubMed · Cited by 1,177
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & Schleifer, K.-H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,175
Franks, A. H., Harmsen, H. J. M., Raangs, G. C., Jansen, G. J., Schut, F., & Welling, G. W. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.9.3336-3345.1998 · Cited by 1,056
Self-citationLangendijk, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M. H., & Welling, G. W. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.8.3069-3075.1995 · Cited by 975
DGGE/TGGE a method for identifying genes from natural ecosystems
Muyzer, G. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80055-1 · Cited by 902
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
Van der Waaij, D., Berghuis-de Vries, J. M., & Lekkerkerk-van der Wees, J. E. C. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 901
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
Sonis, S. T., Oster, G., Fuchs, H., Bellm, L., Bradford, W. Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J. B., LeVeque, F. G., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2201 · Cited by 678
The role of microbiota in infectious disease
Stecher, B., & Hardt, W.-D. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 535
Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces
Harmsen, H. J. M., Raangs, G. C., He, T., Degener, J. E., & Welling, G. W. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.6.2982-2990.2002 · Cited by 401
Self-citationElting, L. S., Bodey, G. P., & Keefe, B. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1201 · Cited by 377
Watanabe, K., Kodama, Y., & Harayama, S. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00220-2 · Cited by 359
Fever and infection in leukemic patients.A study of 494 consecutive patients
Bodey, G. P., Rodriguez, V., Chang, H.-Y., & Narboni, G. (1978) · Cancer · doi:10.1002/1097-0142(197804)41:4<1610::aid-cncr2820410452>3.0.co;2-b · Cited by 325
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
Gibson, B. E. S., Wheatley, K., Hann, I. M., Stevens, R. F., Webb, D., Hills, R. K., De Graaf, S. S. N., Harrison, C. J., & for the United Kingdom Childhood Leukaemia Working Party, A. T. D. C. O. G. (2005) · Leukemia · doi:10.1038/sj.leu.2403924 · Cited by 303
Hann, I., Viscoli, C., Paesmans, M., Gaya, H., Glauser, M., & the International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4453255.x · Cited by 279
Blijlevens, N., Donnelly, J., & De Pauw, B. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702447 · Cited by 266
Suau, A., Rochet, V., Sghir, A., Gramet, G., Brewaeys, S., Sutren, M., Rigottier-Gois, L., & Doré, J. (2001) · Systematic and Applied Microbiology · doi:10.1078/0723-2020-00015 · Cited by 195
Stringer, A. M., Gibson, R. J., Logan, R. M., Bowen, J. M., Yeoh, A. S., & Keefe, D. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.6940 · Cited by 194
Poulsen, L. K., Lan, F., Kristensen, C. S., Hobolth, P., Molin, S., & Krogfelt, K. A. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.5191-5194.1994 · Cited by 192
Jansen, G. J., Wildeboer-Veloo, A. C. M., Tonk, R. H. J., Franks, A. H., & Welling, G. W. (1999) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(99)00049-4 · Cited by 170
Riley, L., Hann, I. M., Wheatley, K., & Stevens, R. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01550.x · Cited by 126
Donskey, C. J., Hujer, A. M., Das, S. M., Pultz, N. J., Bonomo, R. A., & Rice, L. B. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(03)00059-9 · Cited by 118
Whelan, K., Judd, P. A., Preedy, V. R., Simmering, R., Jann, A., & Taylor, M. A. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.8.1896 · Cited by 118
Colonization and infection with vancomycin-resistant enterococcus among patients with cancer
Matar, M. J., Tarrand, J. T., RAAD, I. I., & Rolston, K. V. I. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.04.205 · Cited by 113
Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?
Costa, S. F., Miceli, M. H., & Anaissie, E. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01003-5 · Cited by 113
Bültzingslöwen, I. V., Adlerberth, I., Wold, A. E., Dahlén, G., & Jontell, M. (2003) · Oral Microbiology and Immunology · doi:10.1034/j.1399-302x.2003.00075.x · Cited by 112
Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley, J. S., Taupin, J., Jamieson, G. P., Snook, M. B., Sawyer, W. H., & Finch, L. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111741 · Cited by 101
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci
Sakka, V., Tsiodras, S., Galani, L., Antoniadou, A., Souli, M., Galani, I., Pantelaki, M., Siafakas, N., Zerva, L., & Giamarellou, H. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01840.x · Cited by 94
Total artificial nutrition is associated with major changes in the fecal flora
Schneider, S. M., Gall, P. L., Girard-Pipau, F., Piche, T., Pompei, A., Nano, J. L., Hébuterne, X., & Rampal, P. (2000) · European Journal of Nutrition · doi:10.1007/s003940070003 · Cited by 86
Worth, L. J., Thursky, K., Seymour, J. F., & Slavin, M. A. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00911.x · Cited by 86
Antibacterial activities of antineoplastic agents
Bodet, C. A., Jorgensen, J. H., & Drutz, D. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.437 · Cited by 76
Waar, K., Degener, J. E., van Luyn, M. J. A., & Harmsen, H. J. M. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46022-0 · Cited by 60
Self-citationvan der Waaij, D. (1984) · Antonie van Leeuwenhoek · doi:10.1007/bf02386238 · Cited by 31
Cited by
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
van Vliet, M. J., Harmsen, H. J. M., de Bont, E. S. J. M., & Tissing, W. J. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000879 · Cited by 436
Self-citation
Metadata
- Authors
- van Vliet, M. J., Tissing, W. J. E., Dun, C. A. J., Meessen, N. E. L., Kamps, W. A., de Bont, E. S. J. M., & Harmsen, H. J. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-15
- Volume
- 49
- Issue
- 2
- Pages
- 262-270
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2153820933
- Cited by
- 267
- References
- 38
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.